Procurement Summary
Country: Japan
Summary: Data Management Support for a Multi-Center, Uncontrolled, Open-Label Study (Phase Ii) of Once-Weekly Administration of Fossenvivint in Patients with Liver Cirrhosis Caused by Co-Infection with Hemophilia-Associated Human Immunodeficiency Virus and...
Deadline: 09 Jul 2026
Posting Date: 25 Jun 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 143980051
Document Ref. No.:
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Data management support for a multi-center, uncontrolled, open-label study (Phase II) of once-weekly administration of fossenvivint in patients with liver cirrhosis caused by co-infection with hemophilia-associated human immunodeficiency virus and hepatitis C virus. Description: Data management support for a multi-center, uncontrolled, open-label study (Phase II) of once-weekly administration of fossenvivint in patients with liver cirrhosis caused by co-infection with hemophilia-associated human immunodeficiency virus and hepatitis C virus. 1. Competition... Deadline: 2026-07-09 [Disclaimer: This notice does not specify a specific deadline, so we have added 15 days from the date of posting]
Documents
Tender Notice